Glaxo's $25 bln buyback softens Avandia blow

(Reuters) - By Ben Hirschler, European Pharmaceuticals Correspondent



LONDON, July 25 - GlaxoSmithKline more than doubled its share buyback programme to 12 billion pounds


Read more at Reuters.com Bonds News